Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 1, 2006, Pages 497-505

  Vyas, Piyush M ^a   Roychowdhury, Sanjoy ^a   Koukouritaki, Sevasti B ^c   Hines, Ronald N ^c   Krueger, Sharon K ^d   Williams, David E ^d   Nauseef, William M ^b   Svensson, Craig K ^a,e  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^d OREGON STATE UNIVERSITY   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOHYDRAZIDE; DAPSONE; DIMETHYLANILINE MONOOXYGENASE; HYDRAZIDE DERIVATIVE; LACTOPEROXIDASE; MYELOPEROXIDASE; PEROXIDASE; PROTEIN; SULFAMETHOXAZOLE; THYROID PEROXIDASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOOXIDATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HAPTENATION; PROTEIN METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; XENOBIOTIC METABOLISM;

CELLS, CULTURED; DAPSONE; HAPTENS; HUMANS; IODIDE PEROXIDASE; KERATINOCYTES; LACTOPEROXIDASE; OXYGENASES; PEROXIDASE; PEROXIDASES; SULFAMETHOXAZOLE;

EID: 33749010103     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.105874     Document Type: Article

References (40)

1. Ator MA, David SK, and Ortiz de Montellano PR (1987) Structure and catalytic mechanism of horseradish peroxidase: regiospecific meso alkylation of the prosthetic heme group by alkylhydrazines. J Biol Chem 262:14954-14960.
2. Borregaard N, Heiple JM, Simons ER, and Clark RA (1983) Subcellular localization of the β-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol 97:52-61.
3. Cashman JR (2000) Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism. Curr Drug Metab 1:181-191.
4. Chung WG, Park CS, Roh HK, Lee WK, and Cha YN (2000) Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450. Jpn J Pharmacol 84:213-220.
5. Coleman MD, Rhodes LE, Scott AK, Verbov JL, Friedmann PS, Breckenridge AM, and Park BK (1992) The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. Br J Clin Pharmacol 34:244-249.
6. Cornejo L, Lopez de Blanc S, Femopase F, Azcurra A, Calamari S, Battellino L, and Dorronsoro de Cattoni S (1998) Evolution of saliva and serum components in patients with oral candidosis topically treated with Ketoconazole and Nystatin. Acta Odontol Latinoam 11:15-25.
7. Cribb AE, Miller M, Tesoro A, and Spielberg SP (1990) Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs. Mol Pharmacol 38:744-751.
8. Cribb AE, Spielberg SP, and Griffin GP (1995) N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab Dispos 23:406-414.
9. Goebel C, Vogel C, Wulferink M, Mittmann S, Sachs B, Schraa S, Abel J, Degen G, Uetrecht J, and Gleichmann E (1999) Procainamide, a drug causing lupus, induces prostaglandin H synthase-2 and formation of T cell-sensitizing drug metabolites in mouse macrophages. Chem Res Toxicol 12:488-500.
10. Gorlewska-Roberts KM, Teitel CH, Lay JJ, Roberts DW, and Kadlubar FF (2004) Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines. Chem Res Toxicol 17:1659-1666.
11. Gupta A, Eggo MC, Uetrecht JP, Cribb AE, Daneman D, Rieder MJ, Shear NH, Cannon M, and Spielberg SP (1992) Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther 51:56-67.
12. Henderson MC, Krueger SK, Siddens LK, Stevens JF, and Williams DE (2004) S-oxygenation of the thioether organophosphate insecticides phorate and disulfoton by human lung flavin-containing monooxygenase 2. Biochem Pharmacol 68:959-967.
13. Janmohamed A, Dolphin CT, Phillips IR, and Shephard EA (2001) Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem Pharmacol 62:777-786.
14. Kettle AJ, Gedye CA, Hampton MB, and Winterbourn CC (1995) Inhibition of myeloperoxidase by benzoic acid hydrazides. Biochem J 308:559-563.
15. Kettle AJ, Gedye CA, and Winterbourn CC (1997) Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide. Biochem J 321:503-508.
16. Kettle AJ and Winterbourn CC (1994) Assays for the chlorination activity of myeloperoxidase. Meth Enzymol 233:502-512.
17. Koukouritaki SB and Hines RN (2005) Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development. Pharmacogenomics 6:807-822.
18. Krolicki A (2002) Skin penetration of sulfamethoxazole and trimethoprim after oral administration. Ann Acad Med Stetin 48:59-73.
19. Krueger SK, Siddens LK, Henderson MC, Andreasen EA, Tanguay RL, Pereira CB, Cabacungan ET, Hines RN, Ardlie KG, and Williams DE (2005) Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics. Pharmacogenet Genomics 15:245-256.
20. Laemmli U (1970) Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature (Lond) 227:680-685.
21. Lin CY, Boland BC, Lee YJ, Salemi MR, Morin D, Miller LA, Plopper CG, and Buckpitt AR (2006) Identification of proteins adducted by reactive metabolites of naphthalene and 1-nitronaphthalene in dissected airways of rhesus macaques. Proteomics 6:972-982.
22. Mitra AK, Thummel KE, Kalhorn TF, Kharasch ED, Unadkat JD, and Slattery JT (1995) Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo. Clin Pharmacol Ther 58:556-566.
23. Nace CG, Genter MB, Sayre LM, and Crofton KM (1997) Effect of methimazole, an FMO substrate and competitive inhibitor, on the neurotoxicity of 3,3′-iminodipropionitrile in male rats. Fundam Appl Toxicol 37:131-140.
24. Naisbitt DJ, Hough SJ, Gill HJ, Pirmohamed M, Kitteringham NR, and Park BK (1999) Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Br J Pharmacol 126:1393-1407.
25. Nauseef WM, Root RK, and Malech HL (1983) Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J Clin Investig 71:1297-1307.
26. Pirmohamed M, Alfirevic A, Vilar J, Stalford A, Wilkins EGL, Sim E, and Park BK (2000) Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity. Pharmacogenetics 10:705-713.
27. Reilly TP, Lash LH, Doll MA, Hein D, W Woster PM, and Svensson CK (2000) A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Investig Dermatol 114:1164-1173.
28. Roychowdhury S and Svensson CK (2005) Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. AAPS J 7:E834-E846
29. Roychowdhury S, Vyas PM, Reilly TP, Gaspari AA, and Svensson CK (2005) Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. J Pharmacol Exp Ther 314:43-52.
30. Slominski A, Wortsman J, Kohn L, Ain KB, Venkataraman G, Pisarchik A, Chung JH, Giuliani C, Thornton M, Slugocki G, et al. (2002) Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Investig Dermatol 119:1449-1455.
31. Svensson CK (2003) Do arylhydroxylamine metabolites mediate the idiosyncratic reactions associated with sulfonamides and sulfones? Chem Res Toxicol 16:1034-1043.
32. Svensson CK, Cowen EW, and Gaspari AA (2001) Cutaneous drug reactions. Pharmacol Rev 53:357-379.
33. Towbin H, Staehelin T, and Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
34. Tucker KA, Lilly MB, Heck L, and Rado TA (1987) Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 70:372-378.
35. Uetrecht JP (1990) Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions. Crit Rev Toxicol 20:213-235.
36. Uetrecht JP (1992) The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metab Rev 24:299-366.
37. Uetrecht J, Zahid N, Shear NH, and Biggar WD (1988) Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells. J Pharmacol Exp Ther 245:274-279.
38. Vyas PM, Roychowdhury S, and Svensson CK (2006) Role of human cyclooxygenase-2 in the bioactivation of dapsone and sulfamethoxazole. Drug Metab Dispos 34:16-18.
39. Vyas PM, Roychowdhury S, Woster PM, and Svensson CK (2005) Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes. Biochem Pharmacol 70:275-286.
40. Winter HR, Wang Y, and Unadkat JD (2000) CYP 2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone. Drug Metab Dispos 28:865-868.